Johnson & Johnson Innovation and Children's National Health System* to Launch JLABS @ Washington, DC at the new Children's National Research and Innovation Campus in 2020

The US Biomedical Advanced Research and Development Authority (BARDA) collaborates with JLABS to stimulate innovation and incubation of technologies that improve health security and response through companies focused on public health threats and emerging infectious diseases.

Institutional trust and misinformation in the response to the 2018–19 Ebola outbreak in North Kivu, DR Congo: a population-based survey

The findings underscore the practical implications of mistrust and misinformation for outbreak control. These factors are associated with low compliance with messages of social and behavioural change and refusal to seek formal medical care or accept vaccines, which in turn increases the risk of spread of Ebola virus disease..

How a Nigerian genome team contained a Lassa fever outbreak with international partners

Years of partnership and preparation between the African Center of Excellence for Genomics of Infectious Disease, the Irrua Specialist Teaching Hospital in Nigeria, and the Massachusetts-based Broad Institute ensured the samples were rapidly sequenced in Nigeria by local labs. This response, marked by cooperation and in-country capability, may be the model for the years ahead, as scientists from both Broad in the US and Nigeria believe the chances are high of emerging virus outbreaks occurring more frequently.

“It’s Really Worrying Right Now.” An Ebola Outbreak in the Democratic Republic of Congo is NOT Under Control

The DRC is a very large country and these cases are so far confined to the eastern part of the country. This is also the region of the Democratic Republic of Congo that has long been mired in conflict and insecurity. In recent weeks, Ebola treatment centers have been attacked forcing medical staff to suspend operations. Meanwhile, new Ebola cases are confirmed on a nearly daily basis.